Literature DB >> 27104919

Association between once- and twice-daily direct oral anticoagulant adherence in nonvalvular atrial fibrillation patients and rates of ischemic stroke.

Mark J Alberts1, W Frank Peacock2, Larry E Fields3, Thomas J Bunz4, Elaine Nguyen5, Dejan Milentijevic3, Jeff R Schein3, Craig I Coleman6.   

Abstract

Entities:  

Keywords:  Anticoagulation; Direct oral anticoagulant; Medication adherence; Nonvalvular atrial fibrillation; Proportion of days covered

Mesh：

Substances：

Year:  2016        PMID： 27104919     DOI： 10.1016/j.ijcard.2016.03.212

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  13 in total

1.  Real-world evidence with apixaban for stroke prevention in patients with nonvalvular atrial fibrillation in Germany: a retrospective study (REASSESS).

Authors:  Craig Ian Coleman; Matthias Antz
Journal:  Intern Emerg Med       Date:  2017-02-13       Impact factor: 3.397

2.  Increased Risk of Stroke Due to Non-adherence and Non-persistence with Direct Oral Anticoagulants (DOACs): Real-World Analyses Using a Nested Case-Control Study from The Netherlands, Italy and Germany.

Authors:  Emily Holthuis; Elisabeth Smits; George Spentzouris; Dominik Beier; Dirk Enders; Rosa Gini; Claudia Bartolini; Giampiero Mazzaglia; Fernie Penning-van Beest; Ron Herings
Journal:  Drugs Real World Outcomes       Date:  2022-07-05

3.  Once versus twice daily direct oral anticoagulants in patients with recent stroke and atrial fibrillation.

Authors:  Alexandros A Polymeris; Annaelle Zietz; Fabian Schaub; Louisa Meya; Christopher Traenka; Sebastian Thilemann; Benjamin Wagner; Lisa Hert; Valerian L Altersberger; David J Seiffge; Flurina Lyrer; Tolga Dittrich; Ines Piot; Josefin Kaufmann; Lea Barone; Ludvig Dahlheim; Sophie Flammer; Nikolaos S Avramiotis; Nils Peters; Gian Marco De Marchis; Leo H Bonati; Henrik Gensicke; Stefan T Engelter; Philippe A Lyrer
Journal:  Eur Stroke J       Date:  2022-05-10

4.  Safety of once- or twice-daily dosing of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with nonvalvular atrial fibrillation: A NOAC-TR study.

Authors:  Sadık Volkan Emren; Mehdi Zoghi; Rida Berilgen; İbrahim Halil Özdemir; Oğuzhan Çelik; Nurullah Çetin; Asım Enhoş; Cemal Köseoğlu; Abdurrahman Akyüz; Volkan Doğan; Fatih Levent; Yüksel Dereli; Tolga Doğan; Özcan Başaran; Ilgın Karaca; Özkan Karaca; Yılmaz Ömür Otlu; Çağlar Özmen; Selvi Coşar; Mutlu Sümerkan; Erdal Gürsul; Sinan İnci; Ersel Onrat; Oktay Ergene
Journal:  Bosn J Basic Med Sci       Date:  2018-05-20       Impact factor: 3.363

5.  Adherence and Persistence with Once-Daily vs Twice-Daily Direct Oral Anticoagulants Among Patients with Atrial Fibrillation: Real-World Analyses from the Netherlands, Italy and Germany.

Authors:  Elisabeth Smits; Felicita Andreotti; Eline Houben; Harry J G M Crijns; Sylvia Haas; George Spentzouris; Tania Schink; Rosa Gini; Claudia Bartolini; Fernie Penning-van Beest; Ron Herings
Journal:  Drugs Real World Outcomes       Date:  2022-01-06

Review 6.  Edoxaban in Atrial Fibrillation and Venous Thromboembolism-Ten Key Questions and Answers: A Practical Guide.

Authors:  Raffaele De Caterina; Walter Ageno; Giuseppe Boriani; Paolo Colonna; Angelo Ghirarduzzi; Giuseppe Patti; Roberta Rossini; Andrea Rubboli; Piercarla Schinco; Giancarlo Agnelli
Journal:  Adv Ther       Date:  2017-02-13       Impact factor: 3.845

Review 7.  Antithrombotic therapies for elderly patients: handling problems originating from their comorbidities.

Authors:  Masahisa Arahata; Hidesaku Asakura
Journal:  Clin Interv Aging       Date:  2018-09-11       Impact factor: 4.458

8.  Clinical presentation, diagnostic findings and management of cerebral ischemic events in patients on treatment with non-vitamin K antagonist oral anticoagulants - A systematic review.

Authors:  Thomas Raphael Meinel; Sebastién Frey; Marcel Arnold; Sarah Kendroud; Urs Fischer; Johannes Kaesmacher; Mirjam Rachel Heldner; Simon Jung
Journal:  PLoS One       Date:  2019-03-29       Impact factor: 3.240

9.  Real-world adherence to oral anticoagulants in atrial fibrillation patients: a study protocol for a systematic review and meta-analysis.

Authors:  Clara L Rodríguez-Bernal; Aníbal García-Sempere; Isabel Hurtado; Yared Santa-Ana; Salvador Peiró; Gabriel Sanfélix-Gimeno
Journal:  BMJ Open       Date:  2018-12-19       Impact factor: 2.692

10.  Electronic monitoring of adherence to once-daily and twice-daily direct oral anticoagulants in patients with atrial fibrillation: Baseline data from the SMAAP-AF trial.

Authors:  Tsuyoshi Shiga; Toshimi Kimura; Noritoshi Fukushima; Yuji Yoshiyama; Kazunori Iwade; Fumiaki Mori; Yoichi Ajiro; Shoji Haruta; Yuichiro Yamada; Emi Sawada; Nobuhisa Hagiwara
Journal:  J Arrhythm       Date:  2021-03-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.